Acute myeloid leukemia relapse after allogeneic hematopoietic stem cell transplantation: a retrospective study from a single institution.

Cheng-Hsien LinTsung-Chih ChenYu-Hsuan ShihCheng-Wei ChouChiann-Yi HsuPo-Hsien LiChieh-Lin Jerry Teng

Published in: The Journal of international medical research (2022)

Non-CR status before allo-HSCT was a significant risk factor for AML relapse after allo-HSCT. Patients with AML relapse after allo-HSCT had poor outcomes due to a lack of response to salvage remission-induction chemotherapy or treatment-related adverse events.

Keyphrases

acute myeloid leukemia
allogeneic hematopoietic stem cell transplantation
hematopoietic stem cell
free survival
acute lymphoblastic leukemia
combination therapy
disease activity
type diabetes
rheumatoid arthritis
drug induced